BridgeBio Oncology Therapeutics (BBOT) Q2 2026 Earnings

3JunConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-49.62
-33.2
-16.79
-0.38

Details

Expected EPS
-0.5133
Actual EPS
N/A
Surprise EPS
0.51
Surprise Percent
+100%

Description

BridgeBio Oncology Therapeutics (BBOT) will report earnings of for Q2 2026 on June 03, 2026.

0 Comments

Share your thoughts